Idioma:

Design of Substituted Imidazolidinylpiperidinylbenzoic Acids as Chemokine Receptor 5 Antagonists: Potent Inhibitors of R5 HIV‑1 Replication

Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi ; Bourque, Elyse ; McEachern, Ernest ; Metz, Markus ; Harwig, Curtis ; Li, Tong-Shuang ; Yang, Wen ; Bogucki, David ; Zhu, Yongbao ; Langille, Jonathan ; Veale, Duane ; Ba, Tuya ; Bey, Michael ; Baird, Ian ; Kaller, Alan ; Krumpak, Maria ; Leitch, David ; Satori, Michael ; Vocadlo, Krystyna ; Guay, Danielle ; Nan, Susan ; Yee, Helen ; Crawford, Jason ; Chen, Gang ; Wilson, Trevor ; Carpenter, Bryon ; Gauthier, David ; MacFarland, Ron ; Mosi, Renee ; Bodart, Veronique ; Wong, Rebecca ; Fricker, Simon ; Schols, Dominique

Journal of medicinal chemistry, 2013-10, Vol.56 (20), p.8049-8065 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Design of Substituted Imidazolidinylpiperidinylbenzoic Acids as Chemokine Receptor 5 Antagonists: Potent Inhibitors of R5 HIV‑1 Replication
Autor: Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi ; Bourque, Elyse ; McEachern, Ernest ; Metz, Markus ; Harwig, Curtis ; Li, Tong-Shuang ; Yang, Wen ; Bogucki, David ; Zhu, Yongbao ; Langille, Jonathan ; Veale, Duane ; Ba, Tuya ; Bey, Michael ; Baird, Ian ; Kaller, Alan ; Krumpak, Maria ; Leitch, David ; Satori, Michael ; Vocadlo, Krystyna ; Guay, Danielle ; Nan, Susan ; Yee, Helen ; Crawford, Jason ; Chen, Gang ; Wilson, Trevor ; Carpenter, Bryon ; Gauthier, David ; MacFarland, Ron ; Mosi, Renee ; Bodart, Veronique ; Wong, Rebecca ; Fricker, Simon ; Schols, Dominique
Assuntos: Animals ; Anti-HIV Agents - chemical synthesis ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - pharmacology ; Benzoates - chemical synthesis ; Benzoates - chemistry ; Benzoates - pharmacology ; CCR5 Receptor Antagonists ; Cell Survival - drug effects ; Cells, Cultured ; CHO Cells ; Cricetinae ; Cricetulus ; Drug Design ; HEK293 Cells ; HIV-1 - drug effects ; HIV-1 - physiology ; Host-Pathogen Interactions - drug effects ; Humans ; Imidazoles - chemical synthesis ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Imidazolidines - chemistry ; Leukocytes, Mononuclear - cytology ; Leukocytes, Mononuclear - drug effects ; Leukocytes, Mononuclear - virology ; Models, Chemical ; Molecular Structure ; Piperidines - chemistry ; Receptors, CCR5 - genetics ; Receptors, CCR5 - metabolism ; Structure-Activity Relationship ; Virus Replication - drug effects
É parte de: Journal of medicinal chemistry, 2013-10, Vol.56 (20), p.8049-8065
Descrição: The redesign of the previously reported thiophene-3-yl-methyl urea series, as a result of potential cardiotoxicity, was successfully accomplished, resulting in the identification of a novel potent series of CCR5 antagonists containing the imidazolidinylpiperidinyl scaffold. The main redesign criteria were to reduce the number of rotatable bonds and to maintain an acceptable lipophilicity to mitigate hERG inhibition. The structure–activity relationship (SAR) that was developed was used to identify compounds with the best pharmacological profile to inhibit HIV-1. As a result, five advanced compounds, 6d, 6e, 6i, 6h, and 6k, were further evaluated for receptor selectivity, antiviral activity against CCR5 using (R5) HIV-1 clinical isolates, and in vitro and in vivo safety. On the basis of these results, 6d and 6h were selected for further development.
Editor: United States: American Chemical Society
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Design of Substituted Imidazolidinylpiperidinylbenzoic Acids as Chemokine Receptor 5 Antagonists: Potent Inhibitors of R5 HIV‑1 Replication

United States: American Chemical Society

Buscando em bases de dados remotas. Favor aguardar.